Individuals With Chronic Kidney Disease Qualifying for SGLT-2 Inhibitors in the United States and EMPA-KIDNEY Generalizability
JACC Adv
.
2023 May 24;2(4):100349.
doi: 10.1016/j.jacadv.2023.100349.
eCollection 2023 Jun.
Authors
Nicholas Chiu
,
Rahul Aggarwal
,
Leonard Chiu
,
Muthiah Vaduganathan
,
Gregg C Fonarow
,
Deepak L Bhatt
PMID:
38938229
PMCID:
PMC11198316
DOI:
10.1016/j.jacadv.2023.100349
No abstract available